Publish in OALib Journal
APC: Only $99
The Myasthenia gravis (MG) is an
autoimmune disease that affects neuromuscular transmission and leads to a large
variation of sensibility on depolarizing and nondepolarizing neuromuscular blocking
drugs. Sugammadex is a new drug with the capability to successfully revert the nondepolarizing
This case report will show a patient with MG that was scheduled for thymectomy, with the objective to use
sugammadex to reverse a rocuronium induced deep level of neuromuscular block and observing the safe use of sugammadex without complications.